MyMD Pharmaceuticals appoints Mitchell Glass as chief medical officer
PremiumThe FlyMyMD Pharmaceuticals appoints Mitchell Glass as chief medical officer
3M ago
MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech
Premium
The Fly
MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech
4M ago
MyMD Pharmaceuticals Enhances Governance and Financing Structure
Premium
Company Announcements
MyMD Pharmaceuticals Enhances Governance and Financing Structure
5M ago
MyMD Pharmaceuticals announces 1-for-30 reverse stock split
PremiumThe FlyMyMD Pharmaceuticals announces 1-for-30 reverse stock split
7M ago
MyMD Pharmaceuticals announces results from Supera-CBD study
Premium
The Fly
MyMD Pharmaceuticals announces results from Supera-CBD study
11M ago
MyMD Pharma to present  ‘statistically’ significant Phase 2 data for MYMD-1
Premium
The Fly
MyMD Pharma to present ‘statistically’ significant Phase 2 data for MYMD-1
12M ago
MyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
PremiumThe FlyMyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
1y ago
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
Premium
The Fly
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
2y ago
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
Premium
The Fly
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100